ADHD – Daytrana
Methylphenidate Patch approved by the FDA for Treatment of Attention
Deficit Hyperactivity Disorder in Children
April 11th, 2006
|
 |
|
Transdermal
Patches |
|
The Food and Drug
Administration approved the transdermal skin patch that will deliver the
drug methylphenidate, which is a central nervous system (CNS)
stimulant. It was approved on April 6th for treating children with
Attention Deficit Hyperactivity Disorder (ADHD) in children ranging from
6 to 12 years old. The commercial drug name for the methylphenidate
patch is called Daytrana and is the first transdermal skin patch for
treating ADHD. Daytrana is manufactured for Shire US. Inc., by Noven
Pharmaceuticals Inc.
"Daytrana provides
an alternative route of administration for methylphenidate in children
with ADHD,” said Dr. Galson who is the FDA’s Director of the Center for
Drug Evaluation and Research.
According to the
FDA press release there are approximately 3 – 7 percent of school aged
children that have ADHD. Symptoms of ADHD include inability to
concentrate, hyperactivity and impulsiveness. An ADHD child has
problems with school, getting along with their family and peers and may
also have low self-esteem.
The Daytrana patch
is worn on the hip for nine hours each day. The amount of time that a
patch is worn can vary depending on how much methylphenidate is needed
for the treatment of ADHD.
Side effects of
using the Daytrana patch are insomnia, blurred vision, mild skin
irritation or a rash. The child is also more susceptible to slowed
weight gain and slowed growth of height. Children that have cardiac
abnormalities should not use the Daytrana patch because it further
increases the risk of sudden death.
Daytrana can cause
children who have a problem with anxiety to make it even worse and
should not use this medication. There is a chance for allergic
reactions that would make it not useable. It is not recommend for
children with glaucoma. The child should not combine a monoamine
oxidase inhibitor (MAOI) and the use of the Daytrana patch at the same
time. A child with Tourette’s syndrome should not take this medication
either.
Nicole Wilson
Best Syndication
Books on ADHD
Keywords and Misspellings: ADD ADHD attention deficit
disorder atention defecit attension dissorder A.D.H.D. diseese treetment
simptoms symptims drugs diagnoses daytona drug patch daytrayna datrayna
daytrena daytreena |
RSS Attention Deficit Disorder News
